IBDEI11X ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16902,2)
 ;;=^91041
 ;;^UTILITY(U,$J,358.3,16903,0)
 ;;=K71.50^^88^882^25
 ;;^UTILITY(U,$J,358.3,16903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16903,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,16903,1,4,0)
 ;;=4^K71.50
 ;;^UTILITY(U,$J,358.3,16903,2)
 ;;=^5008799
 ;;^UTILITY(U,$J,358.3,16904,0)
 ;;=K71.51^^88^882^26
 ;;^UTILITY(U,$J,358.3,16904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16904,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
 ;;^UTILITY(U,$J,358.3,16904,1,4,0)
 ;;=4^K71.51
 ;;^UTILITY(U,$J,358.3,16904,2)
 ;;=^5008800
 ;;^UTILITY(U,$J,358.3,16905,0)
 ;;=K71.7^^88^882^29
 ;;^UTILITY(U,$J,358.3,16905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16905,1,3,0)
 ;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
 ;;^UTILITY(U,$J,358.3,16905,1,4,0)
 ;;=4^K71.7
 ;;^UTILITY(U,$J,358.3,16905,2)
 ;;=^5008802
 ;;^UTILITY(U,$J,358.3,16906,0)
 ;;=K71.8^^88^882^33
 ;;^UTILITY(U,$J,358.3,16906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16906,1,3,0)
 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
 ;;^UTILITY(U,$J,358.3,16906,1,4,0)
 ;;=4^K71.8
 ;;^UTILITY(U,$J,358.3,16906,2)
 ;;=^5008803
 ;;^UTILITY(U,$J,358.3,16907,0)
 ;;=K71.9^^88^882^34
 ;;^UTILITY(U,$J,358.3,16907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16907,1,3,0)
 ;;=3^Toxic Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16907,1,4,0)
 ;;=4^K71.9
 ;;^UTILITY(U,$J,358.3,16907,2)
 ;;=^5008804
 ;;^UTILITY(U,$J,358.3,16908,0)
 ;;=K75.2^^88^882^20
 ;;^UTILITY(U,$J,358.3,16908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16908,1,3,0)
 ;;=3^Nonspecific Reactive Hepatitis
 ;;^UTILITY(U,$J,358.3,16908,1,4,0)
 ;;=4^K75.2
 ;;^UTILITY(U,$J,358.3,16908,2)
 ;;=^5008826
 ;;^UTILITY(U,$J,358.3,16909,0)
 ;;=K75.3^^88^882^13
 ;;^UTILITY(U,$J,358.3,16909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16909,1,3,0)
 ;;=3^Granulomatous Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,16909,1,4,0)
 ;;=4^K75.3
 ;;^UTILITY(U,$J,358.3,16909,2)
 ;;=^5008827
 ;;^UTILITY(U,$J,358.3,16910,0)
 ;;=K76.6^^88^882^22
 ;;^UTILITY(U,$J,358.3,16910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16910,1,3,0)
 ;;=3^Portal Hypertension
 ;;^UTILITY(U,$J,358.3,16910,1,4,0)
 ;;=4^K76.6
 ;;^UTILITY(U,$J,358.3,16910,2)
 ;;=^5008834
 ;;^UTILITY(U,$J,358.3,16911,0)
 ;;=F20.3^^88^883^31
 ;;^UTILITY(U,$J,358.3,16911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16911,1,3,0)
 ;;=3^Undifferentiated/Atypical Schizophrenia
 ;;^UTILITY(U,$J,358.3,16911,1,4,0)
 ;;=4^F20.3
 ;;^UTILITY(U,$J,358.3,16911,2)
 ;;=^5003472
 ;;^UTILITY(U,$J,358.3,16912,0)
 ;;=F20.9^^88^883^27
 ;;^UTILITY(U,$J,358.3,16912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16912,1,3,0)
 ;;=3^Schizophrenia,Unspec
 ;;^UTILITY(U,$J,358.3,16912,1,4,0)
 ;;=4^F20.9
 ;;^UTILITY(U,$J,358.3,16912,2)
 ;;=^5003476
 ;;^UTILITY(U,$J,358.3,16913,0)
 ;;=F31.9^^88^883^6
 ;;^UTILITY(U,$J,358.3,16913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16913,1,3,0)
 ;;=3^Bipolar Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16913,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,16913,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,16914,0)
 ;;=F31.72^^88^883^7
 ;;^UTILITY(U,$J,358.3,16914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16914,1,3,0)
 ;;=3^Bipolr Disorder,Full Remis,Most Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,16914,1,4,0)
 ;;=4^F31.72
 ;;^UTILITY(U,$J,358.3,16914,2)
 ;;=^5003512
